NCT07512622Not yet recruiting
Asthma Ctrl SMART Trial
Improving Medication Adherence Using an Adaptive mHealth Intervention in Adolescents With Asthma.
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness of three intervention strategies: 1. asthma management app (control); 2. Asthma Ctrl; 3. Asthma Ctrl+ on adherence, lung function, and health care utilization at post-intervention and 1- and 6-month follow-up. The third objective is to explore and contrast different challenges and combinations of challenges to identify which are most impactful in determining response to the three intervention strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 389 (estimated)
- First submitted
- 26 Mar 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 1 Jan 2030
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Diseases
- Asthma
- NCT number
- NCT07512622
What you commit to
- Study type: Interventional
- Planned participants: 389
- From 15 Oct 2026 to the primary completion date, 1 Jan 2030
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient receives school administered daily controller medication at the time of the enrollment visit
Other illness
- Diagnosis of serious mental illness (e.g., schizophrenia)
- Diagnosis of pervasive developmental disorder
- Active chronic disease apart from asthma or allergic disease (e.g. Bronchiectasis, pulmonary hypertension, and moderate or severe tracheomalacia)
Other
- Significant cognitive deficits that may interfere with comprehension per medical team or chart review
Who the study is looking for
- Patient age between 12-18 years
- Patient is diagnosed with severe-persistent or moderate-persistent asthma per NAEPP asthma guidelines
- Patient is prescribed at least one daily inhaled controller medication or a daily combination inhaled corticosteroid and long-acting beta-agonist and a beta-agonist bronchodilator
- English fluency for patient, caregiver, and clinician
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Colorado AMC Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
| Cincinnati Children's Hospital Medical Center Coordinator of this site? Confirm its status | Cincinnati | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.